SUVEN LIFE SCIENCES LIMITED (SUVEN): Financials & Fundamentals History

Share Price

₹258.85

ROCE

-80.0%

Market Cap

₹7310 cr

Revenue (TTM)

₹10 cr

P/S

731.0x

P/B

12.4x

ROE

-69.0%

Operating Margin

-3711.0%

Debt / Equity

0.0x

Promoter Holding

70.1%

12M Momentum

31.0%

52-week range

₹124.11₹403.35

48% of the way from its 52-week low to its high

Price risk

1Y volatility

57.2%

Beta vs sector

1-year daily

1.61

Balance sheet & cash

Debt service

no meaningful debt

Cash from profit, 3Y

operating cash flow ÷ net profit

-2.00x

low

Share count, 1Y

+18.2%

What is the price implying?

Trailing earnings per share are negative, so a P/E-based figure does not exist. See the loss-makers list on the Expectations Gap page for a revenue-based version.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Health Technology The market-wide Expectations lists

What changed?

Oct '26Fell 34% from the Aug 2026 peak to the Oct 2026 low.
Oct '26Volume reached 6.5x its 50-day median on 2026-10-15; price +5.2% that day.
Jul '26Regained the 2025-07 peak, 4 months after the low.
Jul '26Volume reached 11.6x its 50-day median on 2026-07-03; price +10.0% that day.
Jun '26Promoter holding rose 2.8 pts to 70.2%.
Jun '26Share count is up 18.2% over 12 months.
May '26Volume reached 39.7x its 50-day median on 2026-05-18; price +19.6% that day.
Mar '26Fell 57% from the Jul 2025 peak to the Mar 2026 low.

Show 22 earlier events

Feb '26Volume reached 16.4x its 50-day median on 2026-02-04; price +14.6% that day.
Dec '25Promoter holding fell 2.9 pts to 67.4%.
Dec '25FII + DII holding rose 4.3 pts over 2 quarters to 4.6%.
Jul '25Regained the 2019-11 peak, 66 months after the low.
May '25Volume reached 29.8x its 50-day median on 2025-05-13; price +11.9% that day.
Jan '25Volume reached 22.1x its 50-day median on 2025-01-13; price +4.4% that day.
Dec '24Volume reached 6.1x its 50-day median on 2024-12-10; price +7.4% that day.
Jul '24Volume reached 20.2x its 50-day median on 2024-07-08; price +9.7% that day.
Jan '24Volume reached 18.3x its 50-day median on 2024-01-11; price +10.6% that day.
Oct '23Volume reached 25.0x its 50-day median on 2023-10-31; price +8.1% that day.
Sep '23Volume reached 30.3x its 50-day median on 2023-09-13; price +7.4% that day.
Jul '23Share count is up 46.7% over 12 months.
Jun '23Volume reached 9.8x its 50-day median on 2023-06-15; price +0.9% that day.
Jan '23Volume reached 5.3x its 50-day median on 2023-01-19; price +4.8% that day.
Nov '22Volume reached 16.3x its 50-day median on 2022-11-17; price +7.2% that day.
Sep '22Volume reached 14.1x its 50-day median on 2022-09-06; price +11.1% that day.
Jun '22Share count is up 15.4% over 12 months.
Jun '22Volume reached 18.8x its 50-day median on 2022-06-21; price +19.8% that day.
Mar '22Volume reached 27.1x its 50-day median on 2022-03-31; price +12.4% that day.
Oct '21Volume reached 16.8x its 50-day median on 2021-10-07; price +11.0% that day.
Sep '21Volume reached 19.0x its 50-day median on 2021-09-22; price +7.1% that day.
Apr '21Volume reached 20.1x its 50-day median on 2021-04-22; price +18.9% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Are profits backed by cash?

1 of 3 checks are within range, 1 near a threshold, 1 beyond a threshold.
Tap a check to see how it is measured.

Other income reliance—Not enough data

Not enough reported data to compute this.

Tax rate—Not enough data

Not enough reported data to compute this.

Cash conversion—Not enough data

Not enough reported data to compute this.

Free cash flow0 of 5 yrsBeyond threshold

Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history+38 daysNear threshold

Debtor days are above the median of the previous three fiscal years by 38 days (78 vs 40). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress5% of fixed assetsWithin range

Capital work-in-progress is 5% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days—Not enough data

Not enough reported data to compute this.

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

Over 2 years, DIIs added 2.9 pts; promoters added 0.5 pts.
The number of shareholders fell from 74,003 to 66,791 (-10%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change

Promoters69.6%70.1%+0.5 pts

FIIs0.5%0.6%0.0 pts

DIIs0.0%2.9%+2.9 pts

Public and others29.9%26.4%-3.5 pts

Number of shareholders

66,791shareholders-10% since Dec '23

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

How rough has the ride been?

Maximum drawdown-95.0%recovered 2025-07

1-year volatility57.2%annualised

Beta vs sector index1.403-year daily, correlation 0.36

Volume spikes2last 90 sessions, 5x the 50-day median

Monthly share price

Last 90 trading days

Drawdown from peak

Largest drawdowns

-95.0% (2019-11 peak to 2020-01 low, recovered 2025-07)

-57.3% (2025-07 peak to 2026-03 low, recovered 2026-07)

-34.0% (2026-08 peak to 2026-10 low, not yet recovered)

Most recent volume spikes

2026-10-15: 6.5x the 50-day median, price +5.2% that day

2026-07-03: 11.6x the 50-day median, price +10.0% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Where does it rank among Health Technology peers?

Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

ROCE

Op. margin

Revenue growth

Debt/equity ↓

Cash cycle ↓

12M momentum

Nov '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Oct '26

Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Health Technology sector page Watch it move against Health Technology in the Observatory

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

Company	Sector	Similarity	Closest on
QUADRANT FUTURE TEK (QUADFUTURE)	Electronic Technology	53%	promoter holding, ROCE
HINDUSTAN OIL EXPLORATION CO (HINDOILEXP)	Energy Minerals	50%	revenue growth, debt/equity
GOCL CORPORATION (GOCLCORP)	Process Industries	47%	revenue, operating margin
INOX GREEN ENERGY SERVICES (INOXGREEN)	Utilities	47%	operating margin, debt/equity
MMTC (MMTC)	Distribution Services	47%	operating margin, revenue
BAFNA PHARMACEUTICALS (BAFNAPH)	Health Technology	33%	revenue, ROCE
THEMIS MEDICARE (THEMISMED)	Health Technology	33%	operating margin, promoter holding
PANACEA BIOTEC (PANACEABIO)	Health Technology	29%	debt/equity, ROCE

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What happened next to similar setups

Not enough comparable history to show analogs for this company yet.

Methodology

How historical analogs are built

Data as of 2026-10-30. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

Feature	Weight	Non-financial	Financial
P/E	1	yes	yes
P/S	1	yes	—
P/B	1	—	yes
ROCE	1	yes	—
operating margin	1	yes	—
ROE	1	—	yes
debt/equity	0.75	yes	—
interest cover	0.5	yes	—
revenue growth	0.75	yes	yes
12-month momentum	1	yes	yes
drawdown from 12-month high	0.75	yes	yes
size	0.75	yes	yes
volatility	0.5	yes	yes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
Pools: non-financial: 98,221 company-months from 2008 companies; financial: 5,659 company-months from 108 companies. 2313 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Monthly history (94 months)

Month	P/E	Revenue (TTM)	ROE	ROCE	Debt / Equity
2026-10	—	₹10 cr	-69.0%	-80.0%	0.0x
2026-09	—	₹10 cr	-69.0%	-80.0%	0.0x
2026-08	—	₹8 cr	-54.1%	-80.0%	0.0x
2026-07	—	₹8 cr	-54.1%	-80.0%	0.0x
2026-06	—	₹8 cr	-54.1%	-80.0%	0.0x
2026-05	—	₹7 cr	-288.8%	-87.0%	0.0x
2026-04	—	₹7 cr	-288.8%	-87.0%	0.0x
2026-03	—	₹7 cr	-288.8%	-87.0%	0.0x
2026-02	—	₹6 cr	-222.6%	-87.0%	0.0x
2026-01	—	₹6 cr	-222.6%	-87.0%	0.0x
2025-12	—	₹6 cr	-222.6%	-87.0%	0.0x
2025-11	—	₹8 cr	-194.3%	-87.0%	0.0x
2025-10	—	₹8 cr	-194.3%	-87.0%	0.0x
2025-09	—	₹8 cr	-194.3%	-87.0%	0.0x
2025-08	—	₹7 cr	-169.1%	-87.0%	0.0x
2025-07	—	₹7 cr	-169.1%	-87.0%	0.0x
2025-06	—	₹7 cr	-169.1%	-87.0%	0.0x
2025-05	—	₹8 cr	-61.6%	-36.0%	0.0x
2025-04	—	₹8 cr	-61.6%	-36.0%	0.0x
2025-03	—	₹8 cr	-61.6%	-36.0%	0.0x
2025-02	—	₹8 cr	-62.9%	-36.0%	0.0x
2025-01	—	₹8 cr	-62.9%	-36.0%	0.0x
2024-12	—	₹8 cr	-62.9%	-36.0%	0.0x
2024-11	—	₹8 cr	-47.1%	-36.0%	0.0x
2024-10	—	₹8 cr	-47.1%	-36.0%	0.0x
2024-09	—	₹8 cr	-47.1%	-36.0%	0.0x
2024-08	—	₹11 cr	-45.4%	-36.0%	0.0x
2024-07	—	₹11 cr	-45.4%	-36.0%	0.0x
2024-06	—	₹11 cr	-45.4%	-36.0%	0.0x
2024-05	—	₹14 cr	-36.3%	-53.0%	0.0x
2024-04	—	₹14 cr	-36.3%	-53.0%	0.0x
2024-03	—	₹14 cr	-36.3%	-53.0%	0.0x
2024-02	—	₹14 cr	-36.3%	-53.0%	0.0x
2024-01	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-12	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-11	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-10	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-09	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-08	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-07	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-06	—	₹14 cr	-36.3%	-53.0%	0.0x
2023-05	—	₹12 cr	-145.3%	-118.0%	0.0x
2023-04	—	₹12 cr	-145.3%	-118.0%	0.0x
2023-03	—	₹12 cr	-145.3%	-118.0%	0.0x
2023-02	—	₹12 cr	-145.3%	-118.0%	0.0x
2023-01	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-12	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-11	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-10	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-09	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-08	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-07	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-06	—	₹12 cr	-145.3%	-118.0%	0.0x
2022-05	—	₹13 cr	-77.0%	-58.0%	0.0x
2022-04	—	₹13 cr	-77.0%	-58.0%	0.0x
2022-03	—	₹13 cr	-77.0%	-58.0%	0.0x
2022-02	—	₹13 cr	-77.0%	-58.0%	0.0x
2022-01	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-12	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-11	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-10	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-09	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-08	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-07	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-06	—	₹13 cr	-77.0%	-58.0%	0.0x
2021-05	—	₹13 cr	-75.4%	-54.0%	0.0x
2021-04	—	₹13 cr	-75.4%	-54.0%	0.0x
2021-03	—	₹13 cr	-75.4%	-54.0%	0.0x
2021-02	—	₹13 cr	-75.4%	-54.0%	0.0x
2021-01	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-12	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-11	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-10	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-09	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-08	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-07	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-06	—	₹13 cr	-75.4%	-54.0%	0.0x
2020-05	—	₹286 cr	-11.6%	-4.0%	0.0x
2020-04	—	₹286 cr	-11.6%	-4.0%	0.0x
2020-03	—	₹286 cr	-11.6%	-4.0%	0.0x
2020-02	—	₹286 cr	-11.6%	-4.0%	0.0x
2020-01	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-12	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-11	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-10	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-09	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-08	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-07	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-06	—	₹286 cr	-11.6%	-4.0%	0.0x
2019-05	38.7x	₹625 cr	18.7%	24.0%	0.0x
2019-04	37.7x	₹625 cr	18.7%	24.0%	0.0x
2019-03	37.1x	₹625 cr	18.7%	24.0%	0.0x
2019-02	34.2x	₹625 cr	18.7%	24.0%	0.0x
2019-01	27.5x	₹625 cr	18.7%	24.0%	0.0x

Methodology and data notes